This inventor holds 1 USPTO granted patent. Top assignee: University of South Florida. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Gary Brown - Innovator in Neurological Treatment
Introduction
Gary Brown is a notable inventor based in Flourtown, PA (US). He has made significant contributions to the field of neurology through his innovative patent. His work focuses on methods and compositions for treating ischemic neuronal reperfusion injury, which is crucial for patients suffering from various neurological conditions.
Latest Patents
Gary Brown holds a patent for a method and composition aimed at treating ischemic neuronal reperfusion injury. This patent outlines a therapeutic approach that involves the use of an antagonist of the type 3 ryanodine receptor. The treatment is designed to prevent a rise in cytosolic calcium concentration, which can lead to neuronal damage. The therapeutic compositions include dantrolene or aminodantrolene, which are administered to patients to mitigate the risk of calcium-mediated neuronal damage. This method is particularly relevant for conditions such as ischemic optic neuropathy, stroke, and excitotoxic retinal damage in glaucoma.
Career Highlights
Gary Brown is affiliated with the University of South Florida, where he continues to advance his research in neurological treatments. His work has the potential to significantly improve patient outcomes in the field of neurology.
Collaborations
Gary has collaborated with notable colleagues, including Harpal S Mangat and Gerry Ballough, to further enhance the impact of his research and innovations.
Conclusion
Gary Brown's contributions to the treatment of ischemic neuronal reperfusion injury highlight his dedication to advancing medical science. His innovative approaches have the potential to transform the way neurological conditions are treated, ultimately benefiting many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
